ArticleBlood advances2026

Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B-cell lymphoma.

Sang Eun Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.